Identification of somatic mutations in the key Krebs cycle enzymes, namely, the IDH1/2 in low-grade gliomas (astrocytomas, oligodendrogliomas, oligoastrocytomas) and secondary glioblastomas, but not in primary glioblastomas has been a recent focal point in glioma biology [9]. Here, IDH1 is linked to glioblastoma.